El pptido similar al glucagn tipo 1 (GLP-1) es una hormona intestinal que el cuerpo libera de forma natural despus de comer, y los medicamentos que imitan su accin se usan para tratar la diabetes tipo 2 y la obesidad
While no research definitively proves timing affects side effects, some clinicians suggest evening administration for patients experiencing nausea, allowing them to sleep through the period when gastrointestinal effects may be most noticeable
Beyond liver health, these findings contribute to a growing body of evidence that GLP-1based drugs may have benefits well beyond weight loss and diabetes management
[1] [2] Current state of clinical evidence: Several ongoing clinical trials are specifically investigating whether GLP-1 receptor agonists can benefit people with Alzheimer's disease or mild cognitive impairment
10.1530/EJE-17-1017 Eur J Endocrinol
Verification of regulatory compliance is essential before initiating treatment, and healthcare providers must ensure adherence to applicable federal, state, and local regulations